Phentolamine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:56:45Z

Switch SMW query from broadtable to table format for better layout with TOC

← Older revision		Revision as of 21:56, 20 March 2026
Line 70:		Line 70:
	\|?Has Route=Route		\|?Has Route=Route
	\|?Has Population=Population		\|?Has Population=Population
	\|format=~~broadtable~~		\|format=table
	\|headers=plain		\|headers=plain
	\|mainlabel=-		\|mainlabel=-

Danbot: Add SMW Indications by Condition query table

2026-03-20T18:20:05Z

Add SMW Indications by Condition query table

@@ Line 60: / Line 60: @@
 ==Mechanism of Action==
 *[[alpha 1 Blocker|α antagonist]]
 ==See Also==

Elcatracho: /* Mechanism of Action */

2022-01-04T10:38:10Z

Mechanism of Action

← Older revision		Revision as of 10:38, 4 January 2022
Line 60:		Line 60:
	==Mechanism of Action==		==Mechanism of Action==
	*[[alpha 1 Blocker\|α antagonist]]		*[[alpha 1 Blocker\|α antagonist]]

			==See Also==
			*[[Vasopressors]]

	==References==		==References==
	<Epocrates, UpToDate>		<Epocrates, UpToDate>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

ClaireLewis: /* Mechanism of Action */

2019-09-23T21:33:55Z

Mechanism of Action

← Older revision		Revision as of 21:33, 23 September 2019
Line 59:		Line 59:

	==Mechanism of Action==		==Mechanism of Action==
	*[[α antagonist]]		*[[alpha 1 Blocker\|α antagonist]]

	==References==		==References==
	<Epocrates, UpToDate>		<Epocrates, UpToDate>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

ClaireLewis: /* Administration */

2019-09-23T21:33:22Z

Administration

← Older revision		Revision as of 21:33, 23 September 2019
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: [[~~α<sub>~~1~~</sub>~~ Blocker]]; Antidote, Extravasation; [[Antihypertensive]]		*Type: [[Alpha 1 Blocker]]; [[Antidote]], Extravasation; [[Antihypertensive]]
	*Routes of Administration: IV, IM		*Routes of Administration: IV, IM
	*Common Trade Names: OraVerse		*Common Trade Names: OraVerse

ClaireLewis: /* Contraindications */

2019-09-17T19:58:20Z

Contraindications

← Older revision		Revision as of 19:58, 17 September 2019
Line 29:		Line 29:
	*Hypersensitivity to phentolamine or components		*Hypersensitivity to phentolamine or components
	*[[MI]]		*[[MI]]
	*[[CAD]]		*CAD
	*Angina		*Angina
	*Caution if PUD		*Caution if PUD

Neil.m.young: Text replacement - "α 1" to "α₁"

2017-08-18T02:21:07Z

Text replacement - "α 1" to "α<sub>1</sub>"

← Older revision		Revision as of 02:21, 18 August 2017
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: [[α 1 Blocker]]; Antidote, Extravasation; [[Antihypertensive]]		*Type: [[α<sub>1</sub> Blocker]]; Antidote, Extravasation; [[Antihypertensive]]
	*Routes of Administration: IV, IM		*Routes of Administration: IV, IM
	*Common Trade Names: OraVerse		*Common Trade Names: OraVerse

Neil.m.young: Text replacement - "Alpha" to "α"

2017-07-24T01:13:09Z

Text replacement - "Alpha" to "α"

← Older revision		Revision as of 01:13, 24 July 2017
Line 1:		Line 1:
	==Administration==		==Administration==
	*Type: [[~~Alpha~~ 1 Blocker]]; Antidote, Extravasation; [[Antihypertensive]]		*Type: [[α 1 Blocker]]; Antidote, Extravasation; [[Antihypertensive]]
	*Routes of Administration: IV, IM		*Routes of Administration: IV, IM
	*Common Trade Names: OraVerse		*Common Trade Names: OraVerse
Line 59:		Line 59:

	==Mechanism of Action==		==Mechanism of Action==
	*[[~~Alpha~~ antagonist]]		*[[α antagonist]]

	==References==		==References==
	<Epocrates, UpToDate>		<Epocrates, UpToDate>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Mholtz: Text replacement - "prn" to "PRN"

2017-07-07T12:41:04Z

Text replacement - "prn" to "PRN"

← Older revision		Revision as of 12:41, 7 July 2017
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*Pheochromocytomectomy adjunct: 5mg IM/IV q2-4h ~~prn~~		*Pheochromocytomectomy adjunct: 5mg IM/IV q2-4h PRN
	**Start: 1-2h preop		**Start: 1-2h preop

Line 11:		Line 11:
	**Start: within 12h of extravasation		**Start: within 12h of extravasation

	*[[Hypertensive crisis]]: 5mg IM/IV q2-4h ~~prn~~		*[[Hypertensive crisis]]: 5mg IM/IV q2-4h PRN

	==Pediatric Dosing==		==Pediatric Dosing==
	*Pheochromocytomectomy adjunct: 1mg IM/IV q2-4h ~~prn~~		*Pheochromocytomectomy adjunct: 1mg IM/IV q2-4h PRN
	**Start: 1-2h preop		**Start: 1-2h preop

Rossdonaldson1 at 20:14, 29 September 2016

2016-09-29T20:14:20Z

← Older revision		Revision as of 20:14, 29 September 2016
Line 11:		Line 11:
	**Start: within 12h of extravasation		**Start: within 12h of extravasation

	*Hypertensive crisis: 5mg IM/IV q2-4h prn		*[[Hypertensive crisis]]: 5mg IM/IV q2-4h prn

	==Pediatric Dosing==		==Pediatric Dosing==
Line 18:		Line 18:

	==Special Populations==		==Special Populations==
	*Pregnancy Risk Factor: C		*[[Drug ratings in pregnancy\|Pregnancy Risk]] Factor: C

	===Renal Dosing===		===Renal Dosing===
Line 28:		Line 28:
	==Contraindications==		==Contraindications==
	*Hypersensitivity to phentolamine or components		*Hypersensitivity to phentolamine or components
	*MI		*[[MI]]
	*CAD		*[[CAD]]
	*Angina		*Angina
	*Caution if PUD		*Caution if PUD
Line 35:		Line 35:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*MI		*[[MI]]
	*stroke		*[[stroke]]
	*hypotension, severe		*hypotension, severe
	*arrhythmias		*[[arrhythmias]]
	*PUD		*PUD
	*priapism		*[[priapism]]

	===Common===		===Common===
	*tachycardia		*tachycardia
	*weakness		*[[weakness]]
	*dizziness		*[[dizziness]]
	*flushing		*flushing
	*orthostatic hypotension		*orthostatic hypotension
	*nasal congestion		*nasal congestion
	*nausea		*[[nausea]]
	*vomiting		*[[vomiting]]
	*diarrhea		*[[diarrhea]]

	==Pharmacology==		==Pharmacology==
	*Half-life: 19 minutes		*Half-life: 19 minutes
Line 57:		Line 59:

	==Mechanism of Action==		==Mechanism of Action==
	*Alpha antagonist		*[[Alpha antagonist]]

	==References==		==References==
	<Epocrates, UpToDate>		<Epocrates, UpToDate>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]